Depreciation of Evofem Biosciences, Inc. from 31 Mar 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Evofem Biosciences, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
  • Evofem Biosciences, Inc. Depreciation for the quarter ending 31 Mar 2025 was $6,000, a 50% decline year-over-year.
  • Evofem Biosciences, Inc. annual Depreciation for 2025 was $19,000, a 37% decline from 2024.
  • Evofem Biosciences, Inc. annual Depreciation for 2024 was $30,000, a 94% decline from 2023.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Evofem Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $19,000 -$11,000 -37% 01 Jan 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
2024 $30,000 -$447,000 -94% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
2023 $477,000 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY

Evofem Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,000 -$6,000 -50% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $244,000 $12,000 -$233,000 -95% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $477,000 $468,000 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $500,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $200,000 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $245,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.